William L. Bigbee
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Public Health, Toxicology, Obstetrics and GynecologyGoogle:
"William Bigbee"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rahu K, Rahu M, Tekkel M, et al. (2015) Chernobyl cleanup workers from Estonia: cohort description and related epidemiological research. Journal of Radiological Protection : Official Journal of the Society For Radiological Protection. 35: R35-45 |
Mehan MR, Williams SA, Siegfried JM, et al. (2014) Validation of a blood protein signature for non-small cell lung cancer. Clinical Proteomics. 11: 32 |
Zaidi AH, Gopalakrishnan V, Kasi PM, et al. (2014) Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma. Cancer. 120: 3902-13 |
Conley BA, Cavenagh MM, Lively TG, et al. (2012) Criteria for use of omics-based predictors in NCI-sponsored clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 58 |
Bigbee WL, Gopalakrishnan V, Weissfeld JL, et al. (2012) A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 698-708 |
Zhao T, Zeng X, Bateman NW, et al. (2012) Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard. Journal of Proteome Research. 11: 1089-99 |
Romkes M, Nukui T, Buch S, et al. (2012) Abstract 1722: Prognostic markers in early stage non small-cell lung cancer (NSCLC) Cancer Research. 72: 1722-1722 |
Pancoska P, Romkes M, Nukui T, et al. (2012) Abstract 1720: Validation of a 15-gene prognostic signature in stage IB non small-cell lung cancer (NSCLC) Cancer Research. 72: 1720-1720 |
Nolen BM, Langmead CJ, Choi S, et al. (2011) Serum biomarker profiles as diagnostic tools in lung cancer. Cancer Biomarkers : Section a of Disease Markers. 10: 3-12 |
Zeng X, Hood BL, Zhao T, et al. (2011) Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 725-34 |